CannaBiz Invest Asia Draws Global Medical & Industrial Cannabis Industry Players to Bangkok

By: Centre for Management Technology (CMT)
 
1 2 3
#cbizasia19
#cbizasia19
BANGKOK, Thailand - July 16, 2019 - PRLog -- With more Asian countries starting to legalise medical and industrial cannabis use, major cannabis product manufacturers will convene in Bangkok for a timely summit to share insights on this new market.

Aurora Cannabis shares insights on Global Cannabis Market Outlook & Investment Landscape. Day 1 also features sessions from cannabis producers – CannAcubed presenting a case study on 'China's Industrial Hemp Cultivation & Value Chain Investment' and Elixinol Global providing the 'Growth Outlook for Hemp Foods, Protein & the CBD Market in Japan & Globally'. Coffee break sponsor – Medipharm Labs will speak on Australia's Role in APAC Medical Cannabis Market.

Other cannabis producers sharing their perspectives are:

  • Blue Sky Biologicals - Hemp: Beyond CBD & THC, a Whole Plant Model
  • Hikurangi Cannabis Company - Cannabis Legislation in New Zealand: Reflections on Government Efforts to Design World-Leading Medicinal Cannabis & Full Legalisation
  • Bombay Hemp Company Private Limited (BOHECO) - Industrial and Medical Cannabis Investment in India – Scientific and Legal Perspective
  • BOL Pharma - From Farm to Pharmaceutical Products – Israel's Experience

Thailand - the first Southeast Asian country to legalise cannabis use for medical purposes – gathers 2 experts providing details on – 'Understanding the Medical Cannabis Investment Landscape & Regulatory Hurdles in Thailand' - Tilleke & Gibbins International and 'Integration of Medical Cannabis in Thai Traditional Medicine - A Balancing Game' - Dept. of Thai Traditional and Alternative Medicine, Ministry of Health.

Organised by Centre for Management Technology (CMT), the program also features sessions on:

  • The Future of Sustainable Fashion & Hemp Fibres Industry - Kingdom Holdings
  • "Green Green Profits" - The Cultivation of Outdoor Medical Cannabis as a Business Model for Asia - Jacana Holdings
  • Commercialisation of Plant-Derived Cannabinoid Prescription Medicines to Meet Global Demand - MGC Pharmaceuticals
  • Pharmaceutical Development in Man-Made Cannabinoids - Akseera Pharma

In addition, MYM Nutraceuticals, Helius Therapeutics and Cannex Capital join a panel discussion on 'Accessing Capital Markets for Cannabis Investments – Options & Challenges'.

Meet exhibitors Shenzhen Number Energy Saving Corporation and Blue Sky Biologicals among others at the event. For exhibition details, email grace@cmtsp.com.sg

View event website https://www.cmtevents.com/aboutevent.aspx?ev=190819&pu=280839 for registration or call +65 6346 9147 for more details.

End
Email:***@cmtsp.com.sg
Posted By:***@cmtsp.com.sg Email Verified
Tags:Medical Cannabis, #cbizasia19, Cannabiz Invest
Industry:Biotech, Business, Event, Investment, Medical
Location:Bangkok - Bangkok - Thailand
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jul 19, 2019



Like PRLog?
9K2K1K
Click to Share